Diabetes Clinical Trials in Illinois

Showing 61-80 of 474 trials

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

NCT06011798

The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Edema. The main questions the study aims to answer are: * Assess the efficacy of foselutoclax compared to aflibercept * Assess the safety and tolerability of foselutoclax

Diabetic Macular EdemaRetinal DiseaseMacular Edema+6 more

Unity Biotechnology, Inc.52 participantsStarted Aug 2023

Bakersfield, California, United States • Beverly Hills, California, United States • Huntington Beach, California, United States +16 more locations

Active Not RecruitingPhase 2117 miles

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

NCT06238778

The goal of this study is to see if directing insulin to the liver will improve the low blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring to measure the sugar levels in their blood, and work with the doctor to find the best doses. One group of patients will get the liver targeting insulin, and the other group will use insulin they normally use for treating Type 1 diabetes. The participant will be part of the study for up to 32 weeks.

Diabetes Mellitus, Type 1

Diasome Pharmaceuticlas, Inc.227 participantsStarted Jan 2024

Huntington Beach, California, United States • Pasadena, California, United States • Tustin, California, United States +24 more locations

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

Diabetes Trials in Other Cities

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Omnipod 5 System Compared to Pump Therapy

Denosumab for Type 1 Diabetes

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

HbA1c Variation Study

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

The Pediatric Artificial Pancreas Automated Initialization Trial

HLA Demographics Study in Adults With Type 1 Diabetes

DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes

Other Conditions in Illinois